Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 11, 2018
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
Mon, December 10, 2018
[ Mon, Dec 10th 2018
] - WOPRAI
[ Mon, Dec 10th 2018
] - WOPRAI
[ Mon, Dec 10th 2018
] - WOPRAI
[ Mon, Dec 10th 2018
] - WOPRAI
[ Mon, Dec 10th 2018
] - WOPRAI
[ Mon, Dec 10th 2018
] - WOPRAI
Mohit Bansal Maintained (BOLD) at Hold with Decreased Target to $28 on, Dec 10th, 2018
Mohit Bansal of Citigroup, Maintained "Boundless Bio, Inc." (BOLD) at Hold with Decreased Target from $40 to $28 on, Dec 10th, 2018.
Mohit has made no other calls on BOLD in the last 4 months.
There are 3 other peers that have a rating on BOLD. Out of the 3 peers that are also analyzing BOLD, 1 agrees with Mohit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Raju Prasad of "William Blair" Downgraded from Buy to Hold on, Wednesday, November 7th, 2018
These are the ratings of the 2 analyists that currently disagree with Mohit
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $33 on, Friday, October 12th, 2018
- David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $52 on, Monday, October 8th, 2018
